Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety form BALLET (CRAD001YIC04)

التفاصيل البيبلوغرافية
العنوان: Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety form BALLET (CRAD001YIC04)
المؤلفون: Neven, P., Generali, D., Ciruelos, E.M., Lang, I., Gavila, J., Bighin, C., Borms, M., Conte, P., Montemurro, F., Sartori, D., Marini, L., Camozzi, M., Lorizzo, K., Ocak, O., JERUSALEM, Guy
المصدر: Miami Breast Cancer Conference, Miami, United States [US], March 10-13, 2016
سنة النشر: 2016
مصطلحات موضوعية: oncology, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
نوع الوثيقة: conference paper not in proceedings
http://purl.org/coar/resource_type/c_18cp
conferencePaper
اللغة: English
URL الوصول: https://orbi.uliege.be/handle/2268/199570
Rights: restricted access
http://purl.org/coar/access_right/c_16ec
info:eu-repo/semantics/restrictedAccess
رقم الانضمام: edsorb.199570
قاعدة البيانات: ORBi